CN110368490A - Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and preparation method thereof - Google Patents
Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and preparation method thereof Download PDFInfo
- Publication number
- CN110368490A CN110368490A CN201910659547.5A CN201910659547A CN110368490A CN 110368490 A CN110368490 A CN 110368490A CN 201910659547 A CN201910659547 A CN 201910659547A CN 110368490 A CN110368490 A CN 110368490A
- Authority
- CN
- China
- Prior art keywords
- cell
- canine distemper
- plants
- rdpv
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
The present invention relates to Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and preparation method thereof.The bivalent inactivated vaccine effective component includes the Raccoon dog parvovirus VP2 albumen and canine distemper virus inactivation antigen that RDPV-SN1 plants of recombinant baculovirus transfection Sf9 cell culture obtain;There are virulence to return high wind danger for racoon dog canine distemper, parvovirus bigeminal live vaccine by the present invention, and the lower problem of immune efficacy after the generally existing Raccoon dog parvovirus inactivation of bivalent inactivated vaccine used in the market, provide a kind of bivalent inactivated vaccine by Raccoon dog parvovirus VP2 albumen and the higher canine distemper virus inactivation antigen preparation of viral level.The Combined vaccine can be applied to the prevention of two kinds of diseases of Raccoon dog parvovirus enteritis and canine distemper simultaneously;, controllability good, highly-safe with immunogenicity be strong, culture efficiency and high degree of automation, the advantages such as be produced on a large scale; it can reach " needle two is anti-" purpose, have broad application prospects.
Description
Technical field
The present invention relates to a kind of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and preparation method thereof, belong to beast
Use field of biological product.
Background technique
Raccoon dog parvovirus enteritis is the acute, high degree in contact as caused by Parvoviridae parvovirus category Raccoon dog parvovirus
Sexually transmitted disease.Raccoon dog parvovirus enteritis is widely present in world's every country at present, which mainly causes the enteritis of racoon dog, dead
Rate is up to 30%~60%.
Canine distemper is that one kind as caused by paramyxovirus section Morbillivirus canine distemper virus is acute, hot, high degree in contact
Sexually transmitted disease, young animal is mostly acute, lethal is passed through, and adults can be at chronic, persistent infection, and clinical symptoms are with double
Phase body temperature increases, is main feature with catarrhal pneumonia, gastroenteritis, occasionally has nervous symptoms appearance, is easy other secondary bacteriums
The mixed infection and superinfection, the death rate of virus may be up to 80%, be the most serious for endangering China's fur animal farming
One of epidemic disease.Racoon dog canine distemper annual any season can occur, and especially young racoon dog is before and after ablactation and finishing period is quicker
Sense has very high morbidity and mortality.
Since racoon dog canine distemper and Canine Parvovirus Enteritis have the characteristics that morbidity is anxious, lacks specific treatment method, at present still
Using vaccine inoculation as main preventions.
It is sold currently on the market without the dedicated canine distemper of racoon dog, Canine Parvovirus Enteritis vaccine, many raisers use substitution
Vaccine can not obtain preferable immune protective effect, therefore, generally require to carry out secondary immunity to racoon dog, not only improve cost, but also
The workload of raiser is increased, while causing the biggish stress reaction of recoon dog.And canine distemper vaccine is mostly live seedling, there are virulence
Return strong risk;The vaccine of Canine Parvovirus Enteritis preparation is mainly inactivated virus vaccine or live vaccine, and inactivated vaccine is immune
Originality is poor, and live vaccine returns strong risk there are virulence.
Therefore, Raccoon dog parvovirus baculovirus vector, the development of canine distemper bivalent inactivated vaccine are extremely urgent, can effectively control
Racoon dog canine distemper and Canine Parvovirus Enteritis processed realize " needle two is anti-" purpose.
Summary of the invention
We isolate one plant of Raccoon dog parvovirus from the clinical doubtful tiny pathological material of disease of racoon dog, and Successful amplification goes out the tiny disease of the racoon dog
Malicious VP2 gene, we use insect cell baculoviral --- Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus expression system construction
The recombinant baculovirus of expression Raccoon dog parvovirus VP2 albumen, transfects SF9 cell, cultivates and obtain virus-like particle, the virus
Sample particle has good immunogenicity, safety;CDV-11 the plant of canine distemper Natural Avirulent Strain of my company separation, through the training that suspends
It supports, viral level is 107.5TCID50/ ml or more still has preferable immunogenicity to recoon dog after inactivating, safety after inactivation
Property it is high.
The object of the present invention is to provide a kind of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and its preparation sides
Method, to cope with current Raccoon dog parvovirus enteritis and canine distemper prevalence situation.
Technical solution of the present invention
1. a kind of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine, it is characterised in that the effective component of the vaccine
Including RDPV-SN1 plants of recombinant baculovirus express Raccoon dog parvovirus VP2 albumen, CDV-11 plants of inactivation antigens of canine distemper virus,
Aluminium hydroxide gel adjuvant;The described vaccine is for preventing racoon dog canine distemper and Canine Parvovirus Enteritis.
2. Raccoon dog parvovirus enteritis of the present invention, canine distemper bivalent inactivated vaccine, it is characterised in that the racoon dog is thin
Small virus VP2 albumen is RDPV-SN1 plants of transfection Sf9 cells of recombinant baculovirus by expression Raccoon dog parvovirus VP2 albumen, training
It supports to cell and infection acquisition occurs, which is named as Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus recombinant baculovirus
RDPV-SN1 plants, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese Academy of Sciences microorganism was delivered on May 16th, 2019
The preservation of China Committee for Culture Collection of Microorganisms's common micro-organisms center, research institute, deposit number are CGMCC No.17685.
3. Raccoon dog parvovirus enteritis of the present invention, canine distemper bivalent inactivated vaccine, it is characterised in that the canine distemper
Viral CDV-11 plants of inactivation antigen is obtained after BEI is inactivated by CDV-11 plants of canine distemper virus, and the strain is in 2009 07
Deliver within 15th Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Institute of Microorganism, Academia Sinica Chinese microorganism strain guarantor the moon
The preservation of administration committee's common micro-organisms center is hidden, deposit number is CGMCC No.3201.
4. Raccoon dog parvovirus enteritis of the present invention, canine distemper bivalent inactivated vaccine, it is characterised in that expression racoon dog it is thin
RDPV-SN1 plants of recombinant baculovirus of building of small virus VP2 albumen comprises the following steps:
(1) melittin signal peptide (HBM) and beta-actin the building of transfer vector: are added on pVL1393 carrier
Insulator (HS4) sequence constructs transfer vector pVL-HBM-HS4;
(2) building of recombinant transfer vector: Raccoon dog parvovirus RDPV-SN1 plants of VP2 gene is extracted, by the VP2 gene of extraction
(SEQ ID No:3) is cloned into transfer vector pVL-HBM-HS4, obtains recombinant transfer vector pVL-HBM-HS4-VP2;
(3) recombinant baculovirus RDPV-SN1 plants of building: by recombinant transfer vector pVL-HBM-HS4-VP2 and linearisation
Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus (AcMNPV) genomic DNA cotransfection Sf9 cell obtains expression Raccoon dog parvovirus
The recombinant baculovirus of VP2 albumen is named as RDPV-SN1 plants of Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus recombinant baculovirus.
5. Raccoon dog parvovirus enteritis of the present invention, canine distemper bivalent inactivated vaccine, it is characterised in that the system of the vaccine
Preparation Method the following steps are included:
(1) Raccoon dog parvovirus VP2 albumen: eugonic Sf9 cell inoculation bioreactor is selected to carry out the full training that suspends
It supports, inoculum density is 1.5 × 106~2.0 × 106A cell/ml, 27 DEG C of cultures.When Sf9 cell density reaches in bioreactor
To 1.5 × 106~3.0 × 106When a cell/ml, recombinant baculovirus RDPV-SN1 plants, 27 DEG C is inoculated with by MOI=0.2~2.0
72~96h is cultivated, cell culture is harvested, 2%BEI solution is added thereto, makes BEI final concentration of 0.1%, 37 DEG C after mixing
48h is inactivated, to 1% swine erythrocyte hemagglutinative titer >=1:2048,50% sodium thiosulfate is then added into cell culture
Solution, make its final concentration of 0.2%, stir 1h after terminate inactivation;Through sterile and inactivation after the assay was approved to get Raccoon dog parvovirus
VP2 albumen;
(2) canine distemper virus CDV-11 plants of inactivation antigens: select eugonic Vero cell inoculation bioreactor into
Row microcarrier suspension culture, when Vero cell density reaches 2.0 × 10 in bioreactor6~2.5 × 106When a cell/ml,
CDV-11 plants of canine distemper virus are inoculated with by MOI=0.1, are fallen off on a small quantity to 80% or so cell rounding protrusion of micro-carrier surface and having
When, 10~15min is quickly stirred, microcarrier is filtered out with 75 μm or so filter plates, harvests virus liquid, with 20 μm and 5 μm of filter core removals
Cell fragment, harvests cell culture, and canine distemper virus content should be not less than 107.5TCID50/ml;To the cell culture of harvest
Middle addition 2%BEI solution, makes BEI final concentration of 0.1%, and 37 DEG C of inactivation 48h, are then added into cell culture after mixing
50% hypo solution, make its final concentration of 0.2%, stir 1h after terminate inactivation;It is qualified to examine through sterile and inactivation
Afterwards to get CDV-11 plants of inactivation antigens of canine distemper virus;
(3) the Raccoon dog parvovirus VP2 albumen that step (1) obtains is diluted to and 1% swine erythrocyte hemagglutinative titer is not less than
1:256, the CDV-11 plants of inactivation antigens of canine distemper virus obtained with step (2) are uniformly mixed by proper proportion, the hydrogen with sterilizing
Oxidation aluminium glue is carried out adding 1% thimerosal solution with seedling in the ratio of 9:1, make its final concentration of 0.01%, after being sufficiently stirred
?.
Beneficial effect of the present invention
A kind of Raccoon dog parvovirus enteritis of the present invention, canine distemper bivalent inactivated vaccine and preparation method thereof.The present invention relates to
A kind of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine preparation, key is using the rod-shaped disease of insect cell
Poison --- the recombination of Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus expression system construction expression Raccoon dog parvovirus VP2 albumen is rod-shaped
Virus, and the recombinant baculovirus and canine distemper of the production technology production expression Raccoon dog parvovirus VP2 albumen using the culture that suspends
Viral (Natural Avirulent Strain) is mixed with Combined vaccine with aluminium hydroxide gel after inactivating.It is tiny that the Combined vaccine can be used for simultaneously racoon dog
The prevention of two kinds of diseases of viral enteritis and canine distemper has safety and immunogenicity good, is suitble to large-scale industrialized production
The advantages of.
Raccoon dog parvovirus enteritis prepared by the present invention, canine distemper bivalent inactivated vaccine using the culture that suspends production work
Skill, with cultivating, viral level is high, be not necessarily to mixing, differences between batches are small, training method automates, is not necessarily to mass production personnel, training
The advantages that demand area is small, pollution is small, at low cost is supported, successfully solves that spinner culture production efficiency is low, labor intensity is high, product
The problems such as uniformity is poor is production technology preferred in vaccine preparation.
Raccoon dog parvovirus enteritis of the invention, canine distemper bivalent inactivated vaccine through safety testing the result shows that, to 2 months
The age above recoon dog single dose inoculation (1ml/ is only), single dose repeated inoculation and overdose inoculation (3.0ml/ is only), are observed after inoculation
21, recoon dog is strong to live, and spirit, diet, excrement are normal, without other abnormal clinical symptoms;Dissect, each internal organs are normal,
Without lesion, i.e., the bivalent inactivated vaccine is to recoon dog safety.After potency test shows single dose vaccine inoculation, racoon dog on the 14th after being immunized
Parvovirus HI antibody reaches protectiveness level;21 days after immune, racoon dog canine distemper virus neutralizing antibody reaches protectiveness level
More than;And it is immune 6 months latter, immune recoon dog still has the resistance to canine distemper virus, parvovirus 100%.Vaccine is exempted from
The epidemic disease phase is set to 6 months, storage life be 2~8 DEG C 18 months.
Microbial resources information of the present invention
A kind of Raccoon dog parvovirus enteritis of the invention, canine distemper bivalent inactivated vaccine, preparation are expression racoon dog with strain
RDPV-SN1 plants of the recombinant baculovirus of parvovirus VP2 albumen is named as Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus weight
Baculoviral RDPV-SN1 plants of group, which delivered Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 on May 16th, 2019
The preservation of China Committee for Culture Collection of Microorganisms's common micro-organisms center, Institute of Microorganism, Academia Sinica, deposit number are
CGMCC No.17685;CDV-11 plants of canine distemper virus delivered BeiChen West Road, Chaoyang District, BeiJing City 1 on 07 15th, 2009
Number No. 3 China Committee for Culture Collection of Microorganisms's common micro-organisms center, Institute of Microorganism, Academia Sinica preservations of institute,
Deposit number is CGMCC No.3201 (referring to CN101612396B).
Detailed description of the invention
Fig. 1 is in Raccoon dog parvovirus VP2 gene PCR amplification figure: 1 is Raccoon dog parvovirus VP2 gene amplification product;2
For blank control;M is DL2000Marker.
Fig. 2 is that bacterium colony PCR verifying VP2 gene is connected in pVL-HBM-HS4 carrier figure: 1-3 is 3 different bacterium colony PCR
Electrophoresis result;4 be blank control;M is DL2000Marker.
Specific embodiment
1. RDPV-SN1 plants of recombinant baculovirus buildings
(1) Raccoon dog parvovirus RDPV-SN1 plants of separation take morbidity racoon dog intestinal contents that suitable physiological saline is added, and are added about
The chloroform of total amount 1/3, sufficiently oscillation 15min, 3000r/min are centrifuged 30min, take supernatant, filtration sterilization, according to MOI be 0.1~
On 0.4 inoculation F81 cell, the MEM culture solution containing 2% newborn bovine serum, 37 DEG C of 96~120h of culture, observation are changed after cell is adherent
Cytopathy, the harvest when the typical parvovirus cytopathy for seine occur, falling off, freezes in -20 DEG C.
Isolated RDPV-SN1 plants of Raccoon dog parvovirus are inoculated in the F81 cell for growing up to 80% single layer, 37 DEG C of cultures 72
~120h, after 75% or more lesion, freeze thawing harvest.
(2) RDPV-SN1 plants of DNA of Raccoon dog parvovirus RDPV-SN1 plants of VP2 gene magnification Raccoon dog parvovirus are template, with
VP2-F, VP2-R carry out PCR amplification as primer, according to the RDPV VP2 gene order design primer announced on GenBank:
VP2-F:5 '-aatgaattca gtgatggagc agttcaacc (EcoR I) -3 ' 29 (sequence 1)
VP2-R:5 '-atgggtacct taatataatt ttctaggtg (Kpn I) -3 ' 29 (sequence 2)
As a result the purpose band for amplifying 1755bp size, is consistent with expected results, and gel electrophoresis result is shown in Fig. 1.Amplification
Segment is following (sequence 3):
(3) PCR product after purification is connect by transfer vector pMD19-VP2 building with identification with pMD19-T carrier, is connected
Product converts DH5 α competent cell, will be coated on the LB solid medium containing Amp after culture bacterium solution concentration, 37 DEG C of cultures
16h carries out bacterium colony PCR identification after the bacterium colony culture on picking plate, as a result amplifies the purpose band of 1.7kb size.Sequencing,
It as a result is 1755bp, sequence is as shown in SEQ ID NO:3.Show that RDPV-SN1 plants of VP2 gene successful clones of Raccoon dog parvovirus arrive
On pMD19-T carrier.There is the pMD19-T plasmid of RDPV-SN1 plants of VP2 genes of Raccoon dog parvovirus to be named as pMD-VP2 clone.
(4) transfer vector pVL-HBM building and identification
Using pMD19-HBM plasmid as template, HBM-F, HBM-R carry out the amplification of HBM gene PCR as primer.Primer sequence
It is classified as:
HBM-F:5 '-agcggatcca aaccatgaaa ttc-3 ' (BamH I) 23 (sequence 4)
HBM-R:5 '-ataagatctg catgcggtac ccc-3 ' (Pst I) 23 (sequence 5)
HBM gene magnification PCR product is obtained, purpose band size is 170bp.It is right with restriction enzyme BamH I/Pst I
HBM gene amplification product and plasmid pVL1393 carry out digestion, and purifying is separately recovered after gel electrophoresis, uses T4DNA ligase
Connection converts DH5 α competent cell.Converted product is inoculated with the LB liquid medium containing Amp, picking single colonie carries out bacterium
Fall PCR identification.It will identify that correct bacterium solution send sequencing company to be sequenced, selection is sequenced correct bacterium solution and saves.
The HBM gene PCR amplification system are as follows: 25 μ l, consisting of: 1 μ l, 2 × Pfu PCR of pMD19-HBM plasmid
10 μ l, 2 × Taq PCR MasterMix of MasterMix 2.5 μ l, upstream and downstream primer 1 μ l, ddH2O 9.5μl;The PCR expands
Increase reaction condition are as follows: 94 DEG C of 5min;95 DEG C of 45min, 60 DEG C of 45min, 72 DEG C of 30min, 30 circulations;72 DEG C of 10min, 4 DEG C of guarantors
Hiding.
The HBM gene endonuclease reaction system are as follows: 50 μ l, consisting of: the DNA fragmentation of HBM gene PCR product glue recycling
10 μ l react 5 I enzyme of μ l, BamH of Buffer, 2 I enzyme of μ l, Pst 2 μ l, ddH2O 31μl。
The pVL1393 plasmid enzyme restriction reaction system are as follows: 50 μ l, consisting of: 5 μ l of pVL1393 plasmid, reacts Buffer
5 I enzyme of μ l, BamH, 2 I enzyme of μ l, Pst 2 μ l, ddH2O 36μl。
The HBM gene and pVL1393 plasmid linked system are as follows: digestion HBM gene PCR product 6 μ l, digestion pVL1393
2 μ l of plasmid reacts Buffer 1 μ l, T41 μ l of DNA ligase.
(5) transfer vector pVL-HBM-HS4 building and identification
Using pMD19-HS4 plasmid as template, HS4-F, HS4-R carry out the amplification of HS4 gene PCR as primer.Primer sequence
It is classified as:
HS4-F:5 '-atatacgtag agctcacggg gacagccccc ccccaaag (SnaB I) -3 ' 38 (sequence 6)
HS4-R:5 '-acatacgtaa atattctcac tgactccgtc ctggagtt (SnaB I) -3 ' 38 (sequence 7)
Obtain HS4 gene magnification PCR product, purpose band size about 1.3kb.With restriction enzyme SnaB I to HS4 base
Gene-amplification product and plasmid pVL-HBM carry out digestion, and agarose gel electrophoresis after purification connects target fragment and pVL-HBM carrier
It connects, converts DH5 α competent cell.Converted product is inoculated with the LB liquid medium containing Amp, picking single colonie carries out bacterium colony
PCR identification.It will identify that correct bacterium solution send sequencing company to be sequenced, selection is sequenced correct bacterium solution and saves.
The HS4 gene PCR amplification system are as follows: 25 μ l, consisting of: 1 μ l, 2 × Pfu PCR of pMD19-HS4 plasmid
10 μ l, 2 × Taq PCR MasterMix of MasterMix 2.5 μ l, upstream and downstream primer 1 μ l, ddH2O 9.5μl;The PCR expands
Increase reaction condition are as follows: 94 DEG C of 5min;95 DEG C of 45min, 60 DEG C of 45min, 72 DEG C of 2min, 30 circulations;72 DEG C of 10min, 4 DEG C of guarantors
Hiding.
The HS4 gene endonuclease reaction system are as follows: 50 μ l, consisting of: the DNA fragmentation of HS4 gene PCR product glue recycling
10 μ l react 5 I enzyme of μ l, SnaB of Buffer, 2 μ l, alkaline phosphatase 1 μ l, ddH2O 32μl。
The pVL-HBM plasmid enzyme restriction reaction system are as follows: 50 μ l, consisting of: 5 μ l of pVL-HBM plasmid, reaction
I enzyme of Buffer5 μ l, SnaB, 2 μ l, alkaline phosphatase 1 μ l, ddH2O 32μl。
The HS4 gene and pVL-HBM plasmid linked system are as follows: digestion HS4 gene PCR product 6 μ l, digestion pVL-HBM
2 μ l of plasmid reacts Buffer 1 μ l, T41 μ l of DNA ligase.
(6) transfer vector pVL-HBM-HS4-VP2 building and identification
Transfer vector pVL-HBM-HS4 and pMD-VP2 plasmid are used into I/Kpn of EcoR, I 37 DEG C of digestion 3h, digestion products respectively
It recycles, purify after gel electrophoresis.The VP2 gene of the pVL-HBM-HS4 plasmid of digestion purifying and digestion purifying is used into T4DNA connects
Enzyme connection is connect, DH5 α competent cell is converted.By converted product be inoculated with the LB liquid medium containing Amp, picking single colonie, into
Row bacterium colony PCR identifies purpose band occur at about 1.7kb.Concrete outcome is shown in Fig. 2.To identify correct bacterium solution send sequencing company into
Row sequencing, selection are sequenced correct bacterium solution and save.
The plasmid pVL-HBM-HS4 and pMD-VP2 endonuclease reaction system is equal are as follows: 50 μ l, consisting of: 5 μ l of plasmid, instead
Answer 5 I enzyme of μ l, EcoR of Buffer 2 μ l, Kpn I 2 μ l, ddH2O 36μl。
The pVL-HBM-HS4 plasmid and pMD-VP2 plasmid linked system are as follows: 6 μ l of digestion products VP2 gene, digestion matter
Grain 2 μ l of pVL-HBM-HS4, reacts Buffer 1 μ l, T41 μ l of DNA ligase.
(7) transfection and purifying of recombinant baculovirus
1) it transfects the transfer vector pVL-HBM-HS4-VP2 for constructing success and linearisation Autographa californica multicapsid nucleopolyhedrosisvirus caryogram is polygonal
Precursor virus genomic DNA cotransfection Sf9 cell, 27 DEG C of cultures to the 3rd day started cytopathy occur, and the 5th day when harvests cell
Culture supernatant.
2) recombinant baculovirus of harvest is carried out plaque purification by plaque purification.In the Tissue Culture Dish that diameter is 6cm
Inoculation 2.0 × 106~2.5 × 106A Sf9 cell, places 5min at room temperature.Gradient dilution (dilution: 10-4~10-7) above-mentioned
Cotransfection viral supernatants are inoculated with the virus liquid of 1.0ml difference dilution in each culture dish, are placed at room temperature for 1h, fill virus
Divide infection cell.Sterile water prepares 2% agarose, adds 2 × Grace culture medium of 1 volume, is uniformly mixed.Abandon cell culture
Culture solution supernatant in ware covers 1% agarose of 4.0ml in cell surface, culture dish is placed on wet ring after agarose solidification
In border, 27 DEG C are cultivated 7, observe plaque.Single plaque agar block inoculation SF-SFM serum free medium on picking culture dish, 4
It DEG C rocks overnight, harvests culture, be inoculated with Sf9 cell, 27 DEG C of 72~96h of culture, harvest cell culture as recombinates rod-shaped
For viral RDPV-SN1 plants of F0 for virus liquid, which is named as the recombination of Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus
RDPV-SN1 plants of baculoviral, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese science was delivered on May 16th, 2019
The preservation of China Committee for Culture Collection of Microorganisms's common micro-organisms center, institute of microbiology, institute, deposit number CGMCC
No.17685。
2. RDPV-SN1 plants of recombinant baculovirus identifications
(1) Sf9 cell density is diluted to 2.0 × 10 by viral subculture6A cell/ml is inoculated with F0 for recombinant baculovirus
RDPV-SN1 plants, 27 DEG C of constant-temperature table cultures are set, revolving speed is 100~105r/min.72~96h is cultivated, cell culture is harvested,
As F1 generation recombinant baculovirus RDPV-SN1 strain virus liquid.
(2) PAGE gel electrophoresis carries out RDPV-SN1 plants of cell cultures of F1 generation recombinant baculovirus of harvest
SDS-PAGE detection, while using the Sf9 cell for infecting empty baculoviral (no foreign gene baculoviral) as negative control.
Concrete operations are as follows: 5 × Loading Buffer, the boiling water bath 5min of 10 μ l is added in the cell culture for taking 40 μ l to harvest,
12000r/min is centrifuged 1min, takes supernatant to carry out PAGE gel (12%) electrophoresis, takes gel to be dyed, decolourized after electrophoresis
Afterwards, as a result there is obvious purpose band near 65kD in F1 generation recombinant baculovirus RDPV-SN1 plants of cell culture, and infection is empty
The Sf9 cell culture of baculoviral does not occur respective strap.
(3) Western Blot identification carries out RDPV-SN1 plants of cell cultures of F1 generation recombinant baculovirus of harvest
Western Blot detection, while using the Sf9 cell culture for infecting empty baculoviral and Sf9 cell culture as feminine gender
Control.Concrete operations are as follows: 5 × Loading Buffer of 20 μ l, boiling water bath is added in the cell culture for taking 80 μ l to harvest
5min, sampling carry out PAGE gel (12%) electrophoresis.Product after SDS-PAGE electrophoresis is transferred to PVDF and (gathers inclined difluoro
Vinyl film) on film, 2h is closed with 5% skim milk, the anti-recoon dog enteritis virus positive blood in the diluted rabbit source 1:100 is added in rinsing
Clear to be incubated for 2h, rinsing is added the goat anti-rabbit igg antibody that the diluted horseradish peroxidase of 1:2000 (HRP) is marked and is incubated for 2h, drift
It washes, enhanced chemical luminous fluorescent substrate is then added dropwise, is exposed using X-ray film tabletting.
As a result there is apparent purpose band, table at 65kD in F1 generation recombinant baculovirus RDPV-SN1 plants of cell culture
Bright VP2 albumen successful expression in Sf9 cell.
(4) the F1 generation recombinant baculovirus RDPV-SN1 strain virus liquid of harvest is pressed MTT relative effectivenes by viral level measurement
Method (progress [J] microbiology immunology that Huang Shihe, complementary modul pine measure baculovirus titers method is in progress, and 2007
(02): 79-83. viral level) is measured, result is 6.0 × 107.0PFU/ml。
(5) RDPV-SN1 plants of cell cultures of F1 generation recombinant baculovirus of harvest are pressed in expression albumen blood clotting titration
Expression albumen hemagglutinative titer, result 1:2048 are measured according to Raccoon dog parvovirus blood clotting (HA) test method.
(6) expression albumen VP2 determining the protein quantity carries out determining the protein quantity with double antibody sandwich ELISA.As a result F1
It is 72.5mg/L for RDPV-SN1 plants of expression protein contents of recombinant baculovirus.
(7) observation of expression albumen Electronic Speculum surpasses RDPV-SN1 plants of cell cultures of recombinant baculovirus through sucrose density gradient
Speed centrifugation, sucrose solution concentration is respectively 40%, 50%, 60%, centrifugal speed 29000r/min, is centrifuged 2h, then collects
Positioned at the band of 50% and 60% concentration intersection.Virus-like particle sample after a small amount of purifying concentration is added drop-wise to carbon film
On copper mesh, after air-drying, 2% sodium phosphotungstate solution is added dropwise and carries out negative staining, Electronic Speculum is observed, as a result F1 generation recombinant baculovirus RDPV-
The Raccoon dog parvovirus sample particle of SN1 plants of expression is suitable with Raccoon dog parvovirus particle size, morphology is close.
(8) RDPV-SN1 plants of cell culture legs of F1 generation recombinant baculovirus are inoculated 2~12 by safety testing
Susceptible recoon dog 5 of monthly age health, 3.0ml/ only, are observed 10, and as a result all inoculation recoon dogs are strong lives.
(9) seed culture of viruses is inoculated with well-grown Sf9 cell, 27 DEG C of 72~96h of culture, harvest cell training by Study On Immunogenicity
Support object.After binary ethylenimine (BEI) inactivation completely, by cell culture and the aluminium hydroxide gel of sterilizing in the ratio system of 9:1
Standby vaccine, leg inoculate 5 2~12 monthly ages susceptible recoon dogs of health (RDPV HI antibody titer is not higher than 1:4), 1.0ml/
Only, while the identical recoon dog of 5 conditions being taken not to be inoculated with as control.14 days after immune, it is equal that recoon dog RDPV HI antibody titer is immunized
Not less than 1:32, compares recoon dog RDPV HI antibody titer and be not higher than 1:4;Way is gavaged through esophagus respectively to all recoon dogs simultaneously
Diameter is inoculated with Raccoon dog parvovirus RDPV-SN1 strain virus liquid 15ml and (contains 15 × 107.0TCID50), it is observed continuously 10, racoon dog is as a result immunized
Sub all strong work, control recoon dog all fall ill.
3. the preparation and product inspection of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine
(1) vaccine preparation
1) preparation of Raccoon dog parvovirus VP2 albumen: eugonic Sf9 cell inoculation bioreactor is selected to be hanged entirely
Floating culture, inoculum density are 1.5 × 106~2.0 × 106A cell/ml, 27 DEG C of cultures, when Sf9 cell is close in bioreactor
Degree reaches 1.5 × 106~3.0 × 106When a cell/ml, it is inoculated with recombinant baculovirus RDPV-SN1 plants by MOI=0.2~2.0,
27 DEG C of 72~96h of culture harvest cell culture, and 2%BEI solution is added thereto, makes BEI final concentration of 0.1%, after mixing
37 DEG C of inactivation 48h, then into cell culture addition 50% hypo solution, make its final concentration of 0.2%, stirring
Inactivation is terminated after 1h;It examines through sterile and inactivation to get Raccoon dog parvovirus VP2 albumen, to 1% swine erythrocyte hemagglutinative titer >=1:
2048,2~8 DEG C save backup;
2) preparation of canine distemper virus CDV-11 plants of inactivation antigens: eugonic Vero cell inoculation cell culture is selected
Tank carries out microcarrier suspension culture, when Vero cell density reaches 2.0 × 10 in bioreactor6~2.5 × 106A cell/ml
When, it is inoculated with canine distemper virus CDV-11 plants by MOI=0.1, using the DMEM cell culture for containing 2% newborn bovine serum when connecing poison
Liquid, temperature are 34 DEG C, connect different time sampling observation after poison, to 80% or so cell rounding protrusion of micro-carrier surface and have a small amount of
When falling off, 10~15min is quickly stirred, microcarrier is filtered out with 75 μm or so filter plates, virus liquid is harvested, with 20 μm and 5 μm of filter cores
Cell fragment is removed, cell culture is harvested, canine distemper virus content should be not less than 107.5TCID50/ml;It is trained to the cell of harvest
It supports and 2%BEI solution is added in object, make BEI final concentration of 0.1%, 37 DEG C of inactivation 48h after mixing, then into cell culture
Addition 50% hypo solution, make its final concentration of 0.2%, stir 1h after terminate inactivation, through it is sterile and inactivation examine
To get CDV-11 plants of inactivation antigens of canine distemper virus after qualification, 2~8 DEG C are saved backup:
3) the Raccoon dog parvovirus VP2 albumen that step (1) obtains is diluted to 1% swine erythrocyte hemagglutinative titer not less than 1:
256, the CDV-11 plants of inactivation antigens of canine distemper virus obtained with step 2) are uniformly mixed by proper proportion, the hydroxide with sterilizing
Aluminium glue is carried out adding 1% thimerosal solution with seedling in the ratio of 9:1, make its final concentration of 0.01%, it is quantitative after being sufficiently stirred
Packing covers, labeling.
(2) Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine product inspection
1) after character is stood, upper layer is supernatant liquid, and it is in homogenous suspension after shaking that lower layer, which is a small amount of precipitating,.
2) steriling test, loading amount, the antiseptic mercurials determination of residual amount are tested by existing " Chinese veterinary pharmacopoeia " annex, are answered
Asepsis growth.
3) safety verification 2~12 monthly ages susceptible recoon dog of health (RDPV HI antibody titer is not higher than 1:4) 5, each leg
Vaccine 3.0ml is subcutaneously injected, after inoculation, periodically observes daily and measures recoon dog body temperature 1 time (with preceding thermometric time consistency is inoculated with),
It is observed continuously 21.Be inoculated with that recoon dog is all strong to live, spirit, diet, excrement, body temperature compared with inoculation is preceding without significant change, without it
Its abnormal clinical symptom;Or body temperature is increased more than 1 DEG C, but is delaied and should be no more than 2.
4) efficacy test
1. serological method 2~12 monthly ages susceptible recoon dog of health (RDPV HI antibody titer is not higher than 1:4) 5, each leg
Vaccine 1.0ml is subcutaneously injected in portion, while the identical recoon dog of 5 conditions being taken not to be inoculated with as control.14 days after immune, adopt respectively
Blood separates serum, measures RDPV HI antibody titer and canine distemper virus neutralize antibody titers, and recoon dog RDPV HI antibody effect is immunized
Valence should all be not less than 1:32, and control recoon dog RDPV HI antibody titer should all be not higher than 1:4;It 21 days after immune, takes a blood sample, surveys respectively
Determine canine distemper virus neutralize antibody titers, recoon dog canine distemper virus neutralize antibody titers, which are immunized, should all be not less than 1:50, compare racoon dog
Sub- canine distemper virus neutralize antibody titers should all be not higher than 1:4.
2. Immunization method is with 2~12 monthly ages susceptible recoon dog of health (RDPV HI antibody titer is not higher than 1:4) 10, respectively
Vaccine 1.0ml is subcutaneously injected in leg, while the identical recoon dog of 10 conditions being taken not to be inoculated with as control.14 days after immune, at random
It chooses 5 immune recoon dogs and 5 control recoon dogs and gavages approach inoculation Raccoon dog parvovirus RDPV-SN1 strain virus liquid through esophagus respectively
15ml (contains 15 × 107.0TCID50), it is observed continuously 10, control recoon dog answers 100% morbidity, and immune recoon dog answers 100% protection;Exempt from
21 days after epidemic disease, remaining 5 immune recoon dogs and 5 control recoon dog difference collunarium inoculation 2.0ml, intraperitoneal injection 8.0ml are (altogether
10.0ml contains 1.0 × 105.5TCID50) canine distemper virus ZC strain virus liquid, it is observed continuously 21 after attacking poison, control recoon dog answers
100% morbidity, immune recoon dog answer 100% protection.
Embodiment
Following embodiment combination attached drawing further illustrates the present invention.But it is not construed as limiting the scope of the present invention.Ability
Field technique people should be understood that without departing from the spirit and scope of the invention can details to technical solution of the present invention and
Form is modified or is replaced, but these modifications or substitutions are fallen within the protection scope of the present invention.
The RDPV-SN1 plants of suspension culture process researchs of embodiment 1 --- recombinant baculovirus
1. RDPV-SN1 plants of triangular flask culture process researchs of recombinant baculovirus
(1) influence of the cell density to expression albumen hemagglutinative titer
When Sf9 cell density is 1.5 × 106A cell/ml, 2.0 × 106A cell/ml, 2.5 × 106A cell/ml,
3.0×106When a cell/ml, be inoculated with recombinant baculovirus RDPV-SN1 plants by MOI=0.5,60h, 72h after inoculation, 84h,
96h, 108h, 120h sampling, measurement expression albumen hemagglutinative titer.
As a result by the Sf9 cell of the different cell densities of RDPV-SN1 plants of recombinant baculovirus inoculations, the Sf9 cell when connecing poison
Density is 1.5 × 106、2.0×106、2.5×106、3.0×106When a cell/ml, expression albumen hemagglutinative titer is without obvious poor
Different, 72h expression albumen hemagglutinative titer peaks after connecing poison, is not less than 1:2048, and maintain to 96h.Concrete outcome is shown in Table
1。
The different cell density samples of table 1 express albumen hemagglutinative titer
(2) influence of the virus inoculation amount to expression albumen hemagglutinative titer
When Sf9 cell density is 1.5 × 106When a cell/ml, by MOI=0.05,0.1,0.2,0.5,1.0,2.0,
3.0 recombinant baculovirus RDPV-SN1 plants of inoculations, 60h, 72h, 84h, 96h, 108h, 120h are sampled after inoculation, measurement expression egg
White hemagglutinative titer.
As a result when MOI is 0.2,0.5,1.0,2.0, albumen hemagglutinative titer no significant difference is expressed.72h expresses egg after connecing poison
White hemagglutinative titer peaks, and is not less than 1:2048, and maintain to 96h;Proteinemina is expressed when MOI is 0.05,0.1,3.0
Solidifying potency is lower.Concrete outcome is shown in Table 2.
The different infection multiplicity samples of table 2 express albumen hemagglutinative titer
(3) influence of the different harvest times to expression albumen hemagglutinative titer
When Sf9 cell density is 1.5 × 106When a cell/ml, recombinant baculovirus RDPV-SN1 is inoculated with by MOI=0.2
Strain, 60h, 72h, 84h, 96h, 108h, 120h are sampled after inoculation, measurement expression albumen hemagglutinative titer.
As a result 72h expression albumen hemagglutinative titer peaks after connecing poison, and maintains to 96h, and it is equal to express albumen hemagglutinative titer
Not less than 1:2048;120h expression albumen hemagglutinative titer is begun to decline after connecing poison.Concrete outcome is shown in Table 3.
The different harvest time samples of table 3 express albumen hemagglutinative titer
To sum up test result, it is contemplated that the factors such as production, we determine RDPV-SN1 plants of production technologies of recombinant baculovirus
Are as follows: inoculation initial cell density is 1.5 × 106~3.0 × 106A cell/ml, MOI are 0.2~2.0, meet 72~96h after poison,
Harvest cell culture.
2. RDPV-SN1 plants of bioreactor inoculating process tests of recombinant baculovirus
(1) cell inoculation and amplification are cultivated the well-grown Sf9 cell inoculation 30L bioreactor of triangular flask culture,
Inoculum density is set to 1.5 × 106~2.0 × 106A cell/ml, cell culture temperature are 27 DEG C, dissolved oxygen 45%, during culture
Timing sampling observes cell state and records cell density and vigor;Reach 3.0 × 10 to cell density6A cell/ml or more
When, supplemented medium continues culture to cell density and is higher than 3.0 × 106Sf9 cell suspension is transferred to 90L by a cell/ml
It is cultivated in bioreactor, inoculum density is 1.5 × 106~2.0 × 106A cell/ml, timing sampling during culture are seen
It examines cell state and records viable cell density and vigor.Reach 3.0 × 10 to cell density6When a cell/ml or more, training is added
Base is supported, continues culture to cell density and reaches 3.0 × 106Sf9 cell suspension is transferred to 350L cell by a cell/ml or more
It is cultivated in culture tank.It is amplified to 1000L bioreactor culture in the same way.
(2) 1000L bioreactor, which connects poison and tests, reaches 1.5 × 10 to Sf9 cell density in 1000L bioreactor6
A cell/ml, 3.0 × 106When a cell/ml, respectively according to MOI=0.2,2.0 recombinant baculovirus RDPV-SN1 plants of inoculations
Seed culture of viruses is sampled respectively at 72h, 96h, measurement expression albumen hemagglutinative titer.As a result 72h, 96h after poison, expression albumen blood clotting effect are connect
Valence no significant difference is not less than 1:2048.Concrete outcome is shown in Table 4.
4 1000L bioreactor of table connects poison test expression albumen blood clotting titration result
We conducted RDPV-SN1 plants of triangular flask culture process researchs of recombinant baculovirus, are carried out according to test result
Bioreactor process certification test has finally determined that RDPV-SN1 plants of bioreactors of recombinant baculovirus suspend and has cultivated work
Skill: when Sf9 cell density reaches 1.5 × 10 in bioreactor6~3.0 × 106When a cell/ml, by MOI=0.2~2.0
Recombinant baculovirus RDPV-SN1 plants, 27 DEG C of 72~96h of culture of inoculation harvests cell culture.
The CDV-11 plants of suspension culture process researchs of embodiment 2 --- canine distemper virus
1. CDV-11 plants of 7L bioreactor culture process researchs of canine distemper virus
(1) after microcarrier preparation and sterilizing weigh I type microcarrier of Cytodex every time, with no Ca2+、Mg2+PBS
(0.1mol/L, pH value 7.2, similarly hereinafter) cleaning 2~3 times, 121 DEG C of sterilizing 30min of PBS are added.PBS is discarded after sterilizing,
The MEM cell culture fluid containing 8% newborn bovine serum is added, at 36.5 DEG C, containing 5%CO24h is placed in incubator.
(2) Vero cell microcarrier suspension culture selection form is good, eugonic Vero rolling bottle cell, uses EDTA-
Trypsase dispersion liquid digestion prepares cell suspension, is inoculated with stirring-type Tissue Culture Flask, revolving speed 30r/min, and cell density is
4.5×105A cell/ml, microcarrier concentration 4g/L, cultivation temperature are 36.5 DEG C~37.5 DEG C.
(3) influence Vero cell inoculation stirring-type Tissue Culture Flask culture of the cultivation temperature to viral level, when cell is close
Degree reaches 2.0 × 106When a cell/ml, the DMEM cell culture fluid containing 2% newborn bovine serum is changed, is inoculated with dog by MOI=0.1
CDV-11 plants of distemper virus, 31 DEG C, 34 DEG C, 37 DEG C of cultures are set respectively.48h, 72h, 96h, 120h are separately sampled after connecing poison, measurement
Canine distemper virus content.
As a result canine distemper virus cultivates viral level highest under the conditions of 34 DEG C, and the viral level cultivated under the conditions of 37 DEG C is slightly
Viral level under the conditions of lower than 34 DEG C, culture viral level is minimum under the conditions of 31 DEG C.Concrete outcome is shown in Table 5.
The different cultivation temperature sample virus contents of table 5
(4) influence Vero cell inoculation stirring-type Tissue Culture Flask culture of the cell density to viral level when connecing poison, when
Cell density reaches 1.5 × 106A cell/ml, 2.0 × 106A cell/ml, 2.5 × 106A cell/ml, 3.0 × 106It is a thin
When born of the same parents/ml, the DMEM cell culture fluid containing 2% newborn bovine serum is changed, is inoculated with canine distemper virus CDV-11 by MOI=0.1 respectively
Strain, cultivation temperature are 34 DEG C.48h, 72h, 96h, 120h are separately sampled after connecing poison, measure canine distemper virus content.
Cell density is 2.0 × 10 when as a result connecing poison6A cell/ml and 2.5 × 106Viral level is most when a cell/ml
Height, cell density is 1.5 × 10 when connecing poison6A cell/ml and 3.0 × 106Viral level is slightly lower when a cell/ml.According to test
As a result cell density is 2.0 × 10 when production connects poison6~2.5 × 106A cell/ml.Concrete outcome is shown in Table 6.
The different cell density sample virus contents of table 6
(5) influence Vero cell inoculation stirring-type Tissue Culture Flask culture of the poison amount to viral level is connect, cell density is worked as
Reach 2.0 × 106When a cell/ml, change the DMEM cell culture fluid containing 2% newborn bovine serum, respectively by MOI=0.05,
0.1,0.15 canine distemper virus CDV-11 plants of inoculation, cultivation temperature are 34 DEG C.48h, 72h, 96h, 120h are separately sampled after connecing poison,
Measure canine distemper virus content.
Viral level highest when being as a result inoculated with canine distemper virus CDV-11 plants by MOI=0.1, is connect by MOI=0.05,0.15
Viral level, which is below, at canine distemper virus CDV-11 plants of kind is inoculated with canine distemper virus CDV-11 strain virus content by MOI=0.1.
Canine distemper virus when producing is connect into poison amount according to test result and is determined as MOI=0.1.Concrete outcome is shown in Table 7.
7 difference of table connects poison amount sample virus content
(6) influence Vero cell inoculation stirring-type Tissue Culture Flask culture of the serum-concentration to viral level, when cell is close
Degree reaches 2.0 × 106When a cell/ml, the DMEM cell culture fluid containing 0,1%, 2%, 3% newborn bovine serum is changed respectively, is pressed
MOI=0.1 is inoculated with canine distemper virus CDV-11 plants, and cultivation temperature is 34 DEG C.48h, 72h, 96h, 120h are separately sampled after connecing poison,
Measure canine distemper virus content.
As a result with the DMEM cell culture fluid culture virus containing 2%, 3% newborn bovine serum, virus multiplication is very fast, and virus contains
It measures higher;DMEM cell culture fluid culture disease with the DMEM cell culture fluid containing serum-free and containing 1% newborn bovine serum concentration
Viral level is lower when malicious.According to test result, when production culture medium select concentration containing newborn bovine serum for 2% DMEM cell
Culture solution.Concrete outcome is shown in Table 8.
The different serum-concentration sample virus contents of table 8
(7) influence Vero cell inoculation stirring-type Tissue Culture Flask culture of the different harvest times to viral level, when thin
Born of the same parents' density reaches 2.0 × 106When a cell/ml, the DMEM cell culture fluid containing 2% newborn bovine serum is changed, is connect by MOI=0.1
Canine distemper virus CDV-11 plants of kind, cultivation temperature are 34 DEG C.48h, 72h, 96h, 120h are sampled after connecing poison, observe cytopathy feelings
Condition, and measure canine distemper virus content.
48h after poison is met, for cell without obvious lesion, viral level is lower;72h after poison is met, 70%~80% is thin on microcarrier
Born of the same parents are rounded protrusion and lesion occur, and a small amount of cell falls off from microcarrier, and viral level peaks value;Connect 96h after poison, cytopathy
It becomes apparent, 80% or so cell falls off from microcarrier, and dissociate mortality cell in culture medium, and viral level maintains peak
Value;120h after poison is met, almost without normal cell, cell falls off from microcarrier, and almost cell-free on microcarrier, viral level has
Declined.It, can when 80% or so cell rounding protrusion of micro-carrier surface and having falls off on a small quantity the result shows that meet 72~96h after poison
Harvest virus liquid.Concrete outcome is shown in Table 9.
The different harvest times of table 9 influence viral level
According to the above experimental study, it is determined that processing parameter is cultivated in CDV-11 plants of suspensions of canine distemper virus: Vero is thin
It is 2.0 × 10 that born of the same parents, which cultivate to cell density,6~2.5 × 106When a cell/ml, canine distemper virus CDV-11 is inoculated with by MOI=0.1
Strain, culture medium uses the DMEM cell culture fluid containing 2% newborn bovine serum when connecing poison, and cultivation temperature is 34 DEG C, connects difference after poison
Time sampling, observe cell state, when 80% or so cell rounding protrusion of micro-carrier surface and have on a small quantity fall off when, harvest virus
Liquid.
2. bioreactor verification test
(1) bioreactor washing and sterilizing and microcarrier balance clean up bioreactor, 121 DEG C of sterilizing 30min,
After sterilizing, 100% point of correction of slack tank dissolved oxygen electrode is completed.Sterilized microcarrier is squeezed into bioreactor, is added
Equilibrated Medium to minimum volume of culture, equilibration time is no less than 4h.
(2) 42L bioreactor connects poison test Vero cell inoculation 7L bioreactor, when cell density reaches 2.0 ×
106When a cell/ml or more, digestion transfer is carried out, 7L bioreactor cell is transferred to 42L bioreactor culture, inoculation
Density is not less than 4.5 × 105A cell/ml.For cell in 42L bioreactor culture 2~3 days, cell density reached 2.0 × 106
~2.5 × 106When a cell/ml, the DMEM cell culture fluid of 2% newborn bovine serum is changed, is inoculated with hundstaupe pyreticosis by MOI=0.1
CDV-11 plants malicious, cultivation temperature is 34 DEG C, and different time samples after connecing poison, observes cell state, left to micro-carrier surface 80%
Right cell rounding protrusion and have on a small quantity when falling off, quickly stirs 10~15min, filter out microcarrier with 75 μm or so filter plates, harvest
Virus liquid successively removes cell fragment with 20 μm and 5 μm of filter cores, canine distemper virus content is measured by sampling.Canine distemper as the result is shown
Viral level is 107.5TCID50/ ml or more.
We when cultivation temperature, connecing poison cell density, connect malicious amount, serum-concentration, have studied in terms of harvest time five
Canine distemper virus, which suspends, cultivates production technology, and carries out bioreactor process certification test, and dog has been determined according to test result
Distemper virus, which suspends, cultivates production technology are as follows: Vero cell culture to cell density is 2.0 × 106~2.5 × 106A cell/ml
When, it is inoculated with canine distemper virus CDV-11 plants by MOI=0.1, culture medium uses the DMEM cell containing 2% newborn bovine serum when connecing poison
Culture solution, cultivation temperature are 34 DEG C, observe cell state after connecing poison, connect 72~96h after poison, 80% or so cell of micro-carrier surface
When being rounded protrusion and having a small amount of fall off, 10~15min is quickly stirred, microcarrier is filtered out with 75 μm or so filter plates, harvests virus liquid,
Cell fragment is removed with 20 μm and 5 μm of filter cores.
The RDPV-SN1 plants of BEI inactivation technology researchs of embodiment 3 --- recombinant baculovirus
Take RDPV-SN1 plants of each 300ml of cell culture of 001,002,003 batch of recombinant baculovirus, quantitative separating,
100ml/ bottles.2%BEI solution is added in every bottle of cell culture, making its final concentration is respectively 0.05%, 0.1%, 0.2%, is set
37 DEG C inactivation, during which every 4~8h mix 1 time, respectively at for 24 hours, 32h, 40h, 48h sampling, 50% sodium thiosulfate is added
Solution makes 2 times of its final concentration of BEI, and stirring 1h terminates inactivation, and sampling carries out inactivation inspection.
As a result 0.05%BEI solution, 37 DEG C of inactivation 48h, 0.1%BEI solution, 37 DEG C of inactivation 40h, 0.2%BEI solution,
37 DEG C of inactivation 40h, can be RDPV-SN1 plants with complete inactivation recombinant baculovirus, and concrete outcome is shown in Table 10.To guarantee that recombination is rod-shaped
Viral RDPV-SN1 plants of inactivation thoroughly, while considering production cost, determine used in production final concentration of 0.1% BEI, 37 DEG C
Inactivate 48h.
RDPV-SN1 plants of various concentration BEI solution inactivation tests of 10 recombinant baculovirus of table
Note: "+" represents inactivation completely, and "-" representative does not inactivate completely.
The CDV-11 plants of BEI inactivation technology researchs of embodiment 4 --- canine distemper virus
Take CDV-11 plants of each 300ml of cell culture of 001,002,003 batch of canine distemper virus, quantitative separating, 100ml/ bottles.
2%BEI solution is added in every bottle of cell culture, making its final concentration is respectively 0.05%, 0.1%, 0.2%, 37 DEG C of inactivations are set,
Period every 4~8h mix 1 time, respectively at for 24 hours, 32h, 40h, 48h sampling, 50% hypo solution, which is added, makes its end
Concentration is 2 times of BEI, and stirring 1h terminates inactivation, and sampling carries out inactivation inspection.
As a result 0.05%BEI solution, 37 DEG C of inactivation 48h, 0.1%BEI solution, 37 DEG C of inactivation 40h, 0.2%BEI solution,
37 DEG C of inactivation 40h, can be CDV-11 plants with complete inactivation canine distemper virus, and concrete outcome is shown in Table 11.To guarantee canine distemper virus
CDV-11 plants of inactivations thoroughly, while considering production cost, determines the BEI in production using final concentration of 0.1%, 37 DEG C of inactivations
48h。
CDV-11 plants of various concentration BEI solution inactivation tests of 11 canine distemper virus of table
Note: "+" represents inactivation completely, and "-" representative does not inactivate completely.
Embodiment 5 --- the preparation of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine
1. prepared by Raccoon dog parvovirus VP2 albumen
(1) production is prepared with seed culture of viruses
1) it is 1.5 × 10 that seed culture of viruses is inoculated with well-grown, cell density by MOI=0.2~2.0 by seed culture of viruses breeding6~2.0 ×
106The Sf9 cell of a cell/ml, 27 DEG C of 72~96h of culture harvest cell culture, quantitative separating.Indicate title, harvest day
Phase, generation etc..
2) seed culture of viruses is examined
1. viral level is measured by MTT relative effectivenes method, every milliliter of viral level answers >=1.0 × 107.0PFU。
2. pure property is tested by existing " Chinese veterinary pharmacopoeia " annex, should be without bacterium, mould, mycoplasma and exogenous virus
Pollution.
3. specificity
Seed culture of viruses PCR detection is detected with PCR method, the band of about 1.7kb should occurs.
Protein-specific is expressed by recombinant baculovirus RDPV-SN1 plants of cell cultures PBS (0.015mol/L, pH value
It is 6.4, similarly hereinafter) it is diluted to the suspension of 8 blood coagulation units, it mixes well, makees with the Raccoon dog parvovirus specific antisera of equivalent
For neutralization group, while setting up positive controls (RDPV-SN1 plants of cell cultures of recombinant baculovirus are diluted to 8 blood with PBS
The suspension of solidifying unit and the PBS of equivalent are mixed well) and negative control group (PBS), 37 DEG C of neutralization 60min, shaking 2~3 times.In
With after, 96 hole Microhemagglutination plate of V-type is respectively added by above 3 groups, and every group of at least 10 holes, every hole 0.025ml, then every hole is again
1% swine erythrocyte 0.025ml, shake well is added, 2~8 DEG C of 40~50min of effect observe result.Neutralization group and negative control
Group should all not be aggregated, and positive controls should be all aggregated.
3) virus seed subculture should be no more than for 3 generations.
4) 2~8 DEG C of virus seed conservation preservations, storage life are 9 months.
(2) prepared by cell
1) cell recovery takes the Sf9 cell of Liquid nitrogen storage, puts into 37 DEG C of warm water immediately and is quickly dissolved, by Sf9 cell
Suspension 620r/min is centrifuged 5min, abandons supernatant, and cell is resuspended with SF-SFM serum free medium, is placed in the triangle of suitable capacity
Bottle, 27 DEG C of shaking table cultures, revolving speed are 100~105r/min.
2) cell expansion culture works as Sf9 cell density and reaches 3.0 × 106It when a cell/ml or more, is passed on, is inoculated with
Cell density is 1.0 × 106~1.5 × 106A cell/ml, cell are passaged to certain amount, inoculating cell culture tank, 27 DEG C after
Continuous culture.
(3) prepared by antigen for vaccine
1) bioreactor cleaning, sterilizing clean up bioreactor, 121 DEG C of sterilizing 30min, after sterilizing,
Correct dissolved oxygen electrode.
2) cell inoculation and amplification culture select eugonic Sf9 cell, inoculating cell culture tank, and inoculum density is
1.5×106~2.0 × 106A cell/ml, 27 DEG C of cultures are higher than 3.0 × 10 to cell density6When a cell/ml, training is added
Base is supported, continues culture to cell density and is higher than 3.0 × 106When a cell/ml, bioreactor inner cell suspension is transferred to newly
Bioreactor culture, inoculum density are 1.5 × 106~2.0 × 106A cell/ml.
3) poison and harvest are connect when Sf9 cell density reaches 1.5 × 106~3.0 × 106When a cell/ml, by MOI=0.2
~2.0 recombinant baculovirus RDPV-SN1 plants, 27 DEG C of 72~96h of culture of inoculations, harvest cell culture, indicate title, harvest
Date, lot number etc. set -15 DEG C or less preservations, to be checked spare.
(4) inactivate into cell culture addition 2%BEI solution, make its final concentration of 0.1%, 37 DEG C of inactivation 48h;It goes out
After work, into cell culture add 50% hypo solution, make its final concentration of 0.2%, stir 1h after eventually
It only inactivates, 2~8 DEG C of preservations are to be checked spare.
2. CDV-11 plants of semi-finished product preparations of canine distemper virus and inspection
(1) cell prepare recovery Vero cell, growth-promoting media be the cell culture fluid containing 10% newborn bovine serum, set 37 DEG C,
Containing 5%CO2It is cultivated in incubator, when growing up to fine and close single layer, with EDTA- trypsase dispersion liquid vitellophag, passage proliferation
Culture.
(2) preparation of production seed culture of viruses and inspection
1) preparation of production seed culture of viruses takes well-grown Vero cell monolayer, discards growth-promoting media (containing 10% newborn bovine serum
MEM cell culture fluid), seed culture of viruses is added in the ratio of maintaining liquid (the MEM cell culture fluid containing 2% newborn bovine serum) amount 2%
Into maintaining liquid, it is then dispensed into cell bottle, sets 37 DEG C, containing 5%CO2Continue to cultivate in incubator, to 80% or so cell
Occur harvesting when exemplary fusion type cytopathy, freeze thawing 1 time, quantitative separating, freezen protective indicates harvest date, Virus passages
Deng.
2) seed culture of viruses is examined
It is serially diluted, takes 1. seed culture of viruses is carried out 10 times with the MEM cell culture fluid containing 2% newborn bovine serum by viral level
10-4、10-5、10-6、10-74 dilutions are inoculated with 96 porocyte culture plates of Vero cell for having grown up to single layer, each dilution respectively
8 holes of degree inoculation, every 100 μ l of hole, while setting and not connecing 8 holes of poison control.Add the MEM cell culture containing 2% newborn bovine serum in every hole
100 μ l of liquid sets 37 DEG C, containing 5%CO2It is cultivated in incubator, observes 96~120h, recorded the hole count of cytopathy (CPE), press
Reed-Muench method calculates TCID50.Every milliliter of viral level answers >=105.5TCID50。
2. pure property carries out sterile, mycoplasma by existing " Chinese veterinary pharmacopoeia " annex and exogenous virus is examined, sterile, nothing is answered
Mycoplasma growth, also pollutes without exogenous virus.
3. seed culture of viruses is diluted to 10 with sterile saline by specificity3.0TCID50/ ml, with 10 times of diluted canine distemper virus
Specific antisera mixed in equal amounts as neutralization group, while setting and not neutralizing control group and (be diluted to seed culture of viruses with sterile saline
103.0TCID50/ ml is mixed with equivalent MEM cell culture fluid) and cell controls group, 37 DEG C of neutralization 30min.After neutralization respectively
Inoculation has grown up to 24 porocyte culture plates of Vero cell of single layer, and neutralization group is inoculated with 12 holes, the hole 0.5ml/, do not neutralize control group and
Cell controls group is respectively inoculated with 6 holes, the hole 0.5ml/, and every hole adds the MEM cell culture fluid 0.5ml containing 2% newborn bovine serum, sets 37
DEG C, contain 5%CO2It is cultivated in incubator, observes 96~120h.Cytopathy should all not occur in neutralization group and cell controls group, no
Cytopathy should all be occurred by neutralizing control group.
(3) preparation of seedling virus liquid
1) bioreactor cleaning, sterilizing and microcarrier balance clean up bioreactor, 121 DEG C of sterilizing 30min.
The complete microcarrier that will sterilize after sterilizing squeezes into bioreactor, and the MEM cell culture fluid for containing 8% newborn bovine serum is added
It is balanced to minimum volume of culture, equilibration time is no less than 4h.100% point of dissolved oxygen electrode of school is completed during BALANCE CARRIERS
Just.
2) cell inoculation selects well-grown Vero cell monolayer, after EDTA- trypsin digestion, inoculating cell training
Tank is supported, inoculum density is not less than 4.5 × 105A cell/ml, culture medium are the MEM cell culture fluid containing 8% newborn bovine serum,
Continuous culture 2~3 days, when cell density is higher than 2.0 × 106Digestion transfer is carried out when a cell/ml.
3) cell suspension is transferred in digester by cell dissociation transfer, abandons supernatant, PBS is added into digester
(0.01mol/L, pH7.2) is cleaned 2 times, abandons PBS, and trypsase is added and is digested, and is added after digesting completely and is contained 8% new born bovine
The MEM cell culture fluid of serum terminates digestion.Cell suspension is transferred to new bioreactor culture, inoculum density is not less than
4.5×105A cell/ml.
4) it connects poison and harvest cell suspension is transferred to new bioreactor culture 2~3 days, when cell density reaches 2.0
×106~2.5 × 106When a cell/ml, it is inoculated with canine distemper virus CDV-11 plant, using containing 2% newborn bovine serum when connecing poison
DMEM cell culture fluid, temperature are 34 DEG C, and connecing poison amount is MOI=0.1.Different time samples after connecing poison, observes cell state, to
80% or so cell rounding protrusion of micro-carrier surface and have on a small quantity when falling off, 10~15min is quickly stirred, with 75 μm or so filter plates
Microcarrier is filtered out, virus liquid is harvested, successively removes cell fragment with 20 μm and 5 μm of filter cores, title is indicated, the harvest date, criticizes
Number, -15 DEG C or less preservations are to be checked spare.
(4) inspection of semifinished product
1) steriling test is tested by existing " Chinese veterinary pharmacopoeia " annex, answers asepsis growth.
2) viral level is measured by 1.2.1.1, and every milliliter of viral level answers >=107.5TCID50。
(5) inactivate into cell culture addition 2%BEI solution, make its final concentration of 0.1%, 37 DEG C of inactivation 48h;It goes out
After work, into cell culture add 50% hypo solution, make its final concentration of 0.2%, stir 1h after eventually
It only inactivates, 2~8 DEG C of preservations are to be checked spare.
3. inactivation to be examined to qualified RDPV-SN1 plants of cell cultures of recombinant baculovirus and canine distemper with seedling and packing
CDV-11 plants of inactivation antigens are uniformly mixed by proper proportion, are carried out in the ratio of 9:1 with seedling with the aluminium hydroxide gel of sterilizing, then plus
The thimerosal solution for entering 1%, make its final concentration of 0.01%, be sufficiently stirred, quantitative separating, cover, labeling, prepare the tiny disease of racoon dog
Viral enteritis, canine distemper bivalent inactivated vaccine.
Embodiment 6 --- Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine product inspection
1. after character is stood, upper layer is supernatant liquid, it is in homogenous suspension after shaking that lower layer, which is a small amount of precipitating,.
2. steriling test is tested by existing " Chinese veterinary pharmacopoeia " annex, asepsis growth is answered.Inspection result is shown in Table 12.
3. loading quantity inspection is checked by existing " Chinese veterinary pharmacopoeia " annex, regulation should be met.Inspection result is shown in Table 12.
12 loading quantity inspection result of table
4. Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine difference leg were inoculated for 2 monthly ages by safety verification
The susceptible recoon dog of health (RDPV HI antibody titer is not higher than 1:4) 5,3.0ml/, as immune group;Separately take 5 recoon dogs unavoidably
Epidemic disease, as a control group.After inoculation, periodically observes daily and measure recoon dog body temperature 1 time (with preceding thermometric time consistency is inoculated with), continuously
Observation 21 days, as a result immune group recoon dog is all strong lives, and spirit, diet, excrement, body temperature are compared with before inoculation without significant change, nothing
Other abnormal clinical symptoms, locally and systemically adverse reaction caused by not occurring because of vaccine.With control group no significant difference.Specifically
It the results are shown in Table 13.
13 vaccine safety inspection result of table
5. efficacy test
(1) the serological method 2 monthly ages susceptible recoon dog of health (RDPV HI antibody titer is not higher than 1:4) 5, each leg
Vaccine 1.0ml is subcutaneously injected, while the identical recoon dog of 5 conditions being taken not to be inoculated with as control.14 days after immune, to all recoon dogs
It takes a blood sample respectively, carries out the measurement of RDPV HI antibody titer, recoon dog RDPV HI antibody titer is as a result immunized and is not less than 1:32 (protection
Property value for antibody), control recoon dog RDPV HI antibody titer be not higher than 1:4;21 days after immune, take a blood sample respectively to all recoon dogs, into
As a result the measurement of row canine distemper virus neutralize antibody titers is immunized recoon dog canine distemper virus neutralize antibody titers and is not less than 1:50
(protection antibody value), control recoon dog canine distemper virus neutralize antibody titers are not higher than 1:4.Concrete outcome is shown in Table 14.
14 serological method efficacy test result of table
(2) the Immunization method 2 monthly ages susceptible recoon dog of health (RDPV HI antibody titer is not higher than 1:4) 10, each leg
Vaccine 1.0ml is subcutaneously injected, while the identical recoon dog of 10 conditions being taken not to be inoculated with as control.14 days after immune, 5 are randomly selected
Only immune recoon dog and 5 control recoon dogs gavage approach inoculation Raccoon dog parvovirus RDPV-SN1 strain virus liquid 15ml through esophagus respectively
(contain 15 × 107.0TCID50), it is observed continuously 10, control recoon dog 100% falls ill, and recoon dog 100% is immunized and protects;21 after immune
Day, remaining 5 immune recoon dogs and 5 control recoon dog difference collunarium inoculation 2.0ml, (total 10ml contains 1.0 to intraperitoneal injection 8.0ml
×105.5TCID50) canine distemper virus ZC strain virus liquid, it is observed continuously 21 after attacking poison, control recoon dog 100% falls ill, and racoon dog is immunized
Son 100% is protected.Concrete outcome is shown in Table 15, table 16.
15 Raccoon dog parvovirus of table attacks clinical observation result after poison
16 canine distemper virus of table attacks clinical observation result after poison
6. the antiseptic mercurials determination of residual amount is measured by existing " Chinese veterinary pharmacopoeia " annex, regulation should be met.3 batches of epidemic diseases
Seedling result meets regulation, and concrete outcome is shown in Table 17.
17 antiseptic mercurials of table remain measurement
Sequence table
<110>Qilu Animal Health Products Co., Ltd.
<120>Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and preparation method thereof
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 29
<212> DNA
<213>artificial synthesized (VP2-F)
<400> 1
aatgaattca gtgatggagc agttcaacc 29
<210> 2
<211> 29
<212> DNA
<213>artificial synthesized (VP2-R)
<400> 2
atgggtacct taatataatt ttctaggtg 29
<210> 3
<211> 1755
<212> DNA
<213>Raccoon dog parvovirus VP2 gene (VP2)
<400> 3
atgagtgatg gagcagttca accagacggt ggtcaacctg ctgtcagaaa tgaaagagct 60
acaggatctg ggaacgggac tggaggcggg ggtggtggtg gttctggtgg tgtggggatt 120
tctacgggta ctttcaataa tcagacggaa tttaaatttt tggaaaacgg atgggtggaa 180
atcacagcaa actcaagcag acttgtacat ttaaatatgc cagaaagtga aaattataga 240
agagtggttg taaataatat ggataaaact gcagttaatg gaaacatggc tttagatgat 300
attcatgcac aaattgtaac accttggtca ttggttgatg caaatgcttg gggagtttgg 360
tttaatccag gagattggca actaattgtt aatactatga gtgaattgca tttagttagt 420
tttgaacaag aaatttttaa tgttgtttta aagactgttt cagaatctgc tactcagcca 480
ccaactaaag tttataataa tgatttaact gcatcattga tggttgcatt agatagtaat 540
aatactatgc catttactcc agcagctatg agatctgaga cattgggttt ttatccatgg 600
aaaccaacca taccaactcc atggagatat tatttccaat gggatagaac attaatacca 660
tctcatactg gaactagtgg cacaccaaca aatatatacc atggtacaga tccagatgat 720
gttcaatttt atactattga aaattctgtg ccagtacact tactaagaac aggtgatgaa 780
tttgctacag gaacattttt ttttgattgt aaaccatgta gactaacaca tacatggcaa 840
acaaatagag cattgggctt accaccattt ctaaattctt tgcctcaagc tgaaggagct 900
actaactttg gtgatatagg agttcaacaa gataaaagac gtggtgtaac tcaaatggga 960
aatacaaact atattactga agctactatt atgagaccag ctgaggttgg ttatagtgca 1020
ccatattatt cttttgaggc gtctacacaa gggccattta aaacacctat tgcagcagga 1080
cgggggggag cgcaaacaga tgaaaatcaa gcagcagatg gtgatccaag atatgcattt 1140
ggtagacaac atggtcaaaa aactaccaca acaggagaaa cacctgagag atttacatat 1200
atagcacatc aagatacagg aagatatcca gaaggagatt ggattcaaaa tactaacttt 1260
aaccttcctg taacaaatga taatgtattg ctaccaacag atccaattgg aggtaaaaca 1320
ggaattaact atactaatat atttaatact tatggtcctt taactgcatt aaataatgta 1380
ccaccagttt atccaaatgg tcaaatttgg gataaagaat ttgatactga cttaaaacca 1440
agacttcatg taaatgcacc atttgtttgt caaaataatt gtcctggtca attatttgta 1500
aaagttgcgc ctaatttaac aaatgaatat gatcctgatg catctgctaa tatgtcaaga 1560
attgtaactt actcagattt ttggtggaaa ggtaaattag tatttaaagc taaactaaga 1620
gcctctcata cttggaatcc aattcaacaa atgagtatta atgtagataa ccaatttaac 1680
tatctaccaa gtaatattgg aggtatgaaa attgtatttg aaaaatctca actagcacct 1740
agaaaattat attaa 1755
<210> 4
<211> 23
<212> DNA
<213>artificial synthesized (BM-F2)
<400> 4
agcggatcca aaccatgaaa ttc 23
<210> 5
<211> 23
<212> DNA
<213>artificial synthesized (HBM-R)
<400> 5
ataagatctg catgcggtac ccc 23
<210> 6
<211> 38
<212> DNA
<213>artificial synthesized (HS4-F)
<400> 6
atatacgtag agctcacggg gacagccccc ccccaaag 38
<210> 7
<211> 38
<212> DNA
<213>artificial synthesized (HS4-R)
<400> 7
acatacgtaa atattctcac tgactccgtc ctggagtt 38
Claims (5)
1. a kind of Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine, it is characterised in that the effective component of the vaccine includes
Raccoon dog parvovirus VP2 albumen, canine distemper virus CDV-11 plants of inactivation antigens, hydrogen-oxygens of RDPV-SN1 plants of recombinant baculovirus expression
Change aluminium glue adjuvant;
The described vaccine is for preventing racoon dog canine distemper and Canine Parvovirus Enteritis.
2. Raccoon dog parvovirus enteritis as described in claim 1, canine distemper bivalent inactivated vaccine, it is characterised in that the racoon dog is thin
Small virus VP2 albumen is RDPV-SN1 plants of transfection Sf9 cells of recombinant baculovirus by expression Raccoon dog parvovirus VP2 albumen, training
It supports to cell and infection acquisition occurs, which is named as Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus recombinant baculovirus
RDPV-SN1 plants, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese Academy of Sciences microorganism was delivered on May 16th, 2019
The preservation of China Committee for Culture Collection of Microorganisms's common micro-organisms center, research institute, deposit number are CGMCC No.17685.
3. Raccoon dog parvovirus enteritis as described in claim 1, canine distemper bivalent inactivated vaccine, it is characterised in that the canine distemper
Viral CDV-11 plants of inactivation antigen is obtained after BEI is inactivated by CDV-11 plants of canine distemper virus, and the strain is in 2009 07
Deliver within 15th Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Institute of Microorganism, Academia Sinica Chinese microorganism strain guarantor the moon
The preservation of administration committee's common micro-organisms center is hidden, deposit number is CGMCC No.3201.
4. such as claim 1, the 2 Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine, it is characterised in that expression racoon dog
RDPV-SN1 plants of recombinant baculovirus of building of parvovirus VP2 albumen comprises the following steps:
(1) melittin signal peptide (HBM) and beta-actin insulation the building of transfer vector: are added on pVL1393 carrier
Sub (HS4) sequence, constructs transfer vector pVL-HBM-HS4;
(2) building of recombinant transfer vector: Raccoon dog parvovirus RDPV-SN1 plants of VP2 gene is extracted, by the VP2 gene (SEQ of extraction
ID No:3) it is cloned into transfer vector pVL-HBM-HS4, obtain recombinant transfer vector pVL-HBM-HS4-VP2;
(3) recombinant baculovirus RDPV-SN1 plants of building: by recombinant transfer vector pVL-HBM-HS4-VP2 and linearisation clover
Gamma nuclear polyhedrosis virus (AcMNPV) genomic DNA cotransfection Sf9 cell obtains expression Raccoon dog parvovirus VP2 egg
White recombinant baculovirus is named as RDPV-SN1 plants of Autographa californica multicapsid nucleopolyhedrosisvirus nuclear polyhedrosis virus recombinant baculovirus.
5. Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine according to claim 1, it is characterised in that the vaccine
Preparation method the following steps are included:
(1) it Raccoon dog parvovirus VP2 albumen: selects eugonic Sf9 cell inoculation bioreactor to carry out the full culture that suspends, connects
Kind density is 1.5 × 106~2.0 × 106A cell/ml, 27 DEG C of cultures.When Sf9 cell density reaches 1.5 in bioreactor
×106~3.0 × 106When a cell/ml, it is inoculated with recombinant baculovirus RDPV-SN1 plants by MOI=0.2~2.0,27 DEG C of cultures
72~96h harvests cell culture, and 2%BEI solution is added thereto, makes BEI final concentration of 0.1%, 37 DEG C of inactivations after mixing
Then 48h adds 50% hypo solution to 1% swine erythrocyte hemagglutinative titer >=1:2048 into cell culture,
Make its final concentration of 0.2%, stir 1h after terminate inactivation;Through sterile and inactivation after the assay was approved to get Raccoon dog parvovirus VP2 egg
It is white;
(2) canine distemper virus CDV-11 plants of inactivation antigens: eugonic Vero cell inoculation bioreactor is selected to carry out micro-
Carrier, which suspends, to be cultivated, when Vero cell density reaches 2.0 × 10 in bioreactor6~2.5 × 106When a cell/ml, by MOI
=0.1 CDV-11 plant canine distemper virus of inoculation, when 80% or so cell rounding protrusion of micro-carrier surface and when having a small amount of fall off, fastly
Speed 10~15min of stirring, filters out microcarrier with 75 μm or so filter plates, harvests virus liquid, broken with 20 μm and 5 μm of filter core removal cells
Piece, harvests cell culture, and canine distemper virus content should be not less than 107.5TCID50/ml;It is added into the cell culture of harvest
2%BEI solution makes BEI final concentration of 0.1%, 37 DEG C of inactivation 48h after mixing, the then addition 50% into cell culture
Hypo solution, make its final concentration of 0.2%, stir 1h after terminate inactivation;Through it is sterile and inactivation after the assay was approved to get
CDV-11 plants of inactivation antigens of canine distemper virus;
(3) the Raccoon dog parvovirus VP2 albumen that step (1) obtains is diluted to 1% swine erythrocyte hemagglutinative titer not less than 1:
256, the CDV-11 plants of inactivation antigens of canine distemper virus obtained with step (2) are uniformly mixed by proper proportion, the hydrogen-oxygen with sterilizing
Change aluminium glue to carry out adding 1% thimerosal solution with seedling in the ratio of 9:1, make its final concentration of 0.01%, after being sufficiently stirred i.e.
At.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910659547.5A CN110368490B (en) | 2019-07-22 | 2019-07-22 | Raccoon dog parvovirus enteritis and canine distemper bivalent inactivated vaccine and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910659547.5A CN110368490B (en) | 2019-07-22 | 2019-07-22 | Raccoon dog parvovirus enteritis and canine distemper bivalent inactivated vaccine and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110368490A true CN110368490A (en) | 2019-10-25 |
CN110368490B CN110368490B (en) | 2022-08-02 |
Family
ID=68254537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910659547.5A Active CN110368490B (en) | 2019-07-22 | 2019-07-22 | Raccoon dog parvovirus enteritis and canine distemper bivalent inactivated vaccine and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110368490B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110846326A (en) * | 2019-11-29 | 2020-02-28 | 长春工业大学 | Raccoon parvovirus VP2 gene, expression vector, recombinant strain, method for preparing VP2 protein and assembly method |
CN111514288A (en) * | 2020-05-14 | 2020-08-11 | 常州同泰生物药业科技股份有限公司 | Preparation method of canine distemper and canine parvo bivalent inactivated vaccine |
CN113827716A (en) * | 2020-06-23 | 2021-12-24 | 普莱柯生物工程股份有限公司 | Canine distemper virus low-virulent strain, vaccine composition prepared from canine distemper virus low-virulent strain and application of vaccine composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103820398A (en) * | 2014-02-17 | 2014-05-28 | 齐鲁动物保健品有限公司 | Mink enteritis virus recombinant subunit vaccine and preparation method thereof |
CN104258386A (en) * | 2014-09-12 | 2015-01-07 | 齐鲁动物保健品有限公司 | Combination of mink viral enteritis inactivated vaccine and canine distemper live vaccine |
-
2019
- 2019-07-22 CN CN201910659547.5A patent/CN110368490B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103820398A (en) * | 2014-02-17 | 2014-05-28 | 齐鲁动物保健品有限公司 | Mink enteritis virus recombinant subunit vaccine and preparation method thereof |
CN104258386A (en) * | 2014-09-12 | 2015-01-07 | 齐鲁动物保健品有限公司 | Combination of mink viral enteritis inactivated vaccine and canine distemper live vaccine |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110846326A (en) * | 2019-11-29 | 2020-02-28 | 长春工业大学 | Raccoon parvovirus VP2 gene, expression vector, recombinant strain, method for preparing VP2 protein and assembly method |
CN111514288A (en) * | 2020-05-14 | 2020-08-11 | 常州同泰生物药业科技股份有限公司 | Preparation method of canine distemper and canine parvo bivalent inactivated vaccine |
CN113827716A (en) * | 2020-06-23 | 2021-12-24 | 普莱柯生物工程股份有限公司 | Canine distemper virus low-virulent strain, vaccine composition prepared from canine distemper virus low-virulent strain and application of vaccine composition |
Also Published As
Publication number | Publication date |
---|---|
CN110368490B (en) | 2022-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107815441A (en) | A kind of II type Pseudorabies virus attenuated strain and its preparation method and application | |
CN107513524A (en) | One plant of pig Sai Neijia paddy virus stain and its application | |
CN101186902B (en) | Pseudorabies virus SA215, pseudorabies virus polygene deletion bacterin and preparation method thereof | |
CN110368490A (en) | Raccoon dog parvovirus enteritis, canine distemper bivalent inactivated vaccine and preparation method thereof | |
CN106591242A (en) | Canine parvovirus strain CPV-YH and applications thereof | |
CN104587460B (en) | Mink viral enteritis, canine distemper bigeminal live vaccine and its preparation method and application | |
CN107384874A (en) | Pseudorabies virus epidemic strain gI/gE gene deletion mutants and structure and application | |
CN108904796A (en) | Rabbit hemorrhagic disease virus baculovirus vector, pasteurella multocida disease bivalent inactivated vaccine and preparation method thereof | |
CN109182282A (en) | The dual-gene deletion of vaccine strain of porcine pseudorabies virus gE/gI and its construction method and application | |
CN114854697B (en) | Trivalent inactivated vaccine of porcine rotavirus G4-G5-G9 and preparation method and application thereof | |
CN101376878B (en) | Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby | |
CN110201153B (en) | Triple inactivated vaccine for rabbit viral hemorrhagic disease, pasteurellosis and bordetella disease and preparation method thereof | |
CN110124025A (en) | A kind of bird flu and 4 type bigeminy genetic engineering subunit vaccine of aviadenovirus and preparation method thereof | |
CN104056265B (en) | Porcine circovirus 2 type, Porcine reproductive and respiratory syndrome bigeminy vaccine and preparation method thereof | |
CN109207438A (en) | Porcine pseudorabies virus velogen strain and its preparing the application in inactivated vaccine | |
CN108421037A (en) | A kind of porcine pseudorabies/porcine parvovirus bivalent inactivated vaccine and its culture preparation method that suspends | |
CN108704128A (en) | A kind of canine distemper parvovirus bigeminy subunit vaccine | |
CN109097340A (en) | A kind of aviadenovirus, a kind of quadruple vaccine and preparation method thereof | |
CN105903011B (en) | A kind of pseudorabies disease live-vaccine and preparation method thereof | |
CN102727877A (en) | Method for preparing highly pathogenic porcine reproductive and respiratory syndrome live vaccine (JXA1-R strain) by utilizing bioreactor and application thereof | |
CN104388396B (en) | Porcine pseudorabies poison strain and inactivated vaccine prepared therefrom and application | |
CN116426487A (en) | Porcine epidemic diarrhea virus strain and application thereof in vaccine preparation | |
CN106854647A (en) | Duck virus hepatitis divalence yolk antibody and its preparation method and application | |
CN110128545A (en) | A kind of fusion, recombinant expression carrier, antigen and its preparation method and application | |
CN109867713A (en) | A kind of canine distemper genetic engineering subunit vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |